Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial.
Sidney Chocron, Pierre Vandel, Camille Durst...
https://pubmed.ncbi.nlm.nih.gov/23566649Actively Recruiting
Led by Roland von Känel · Updated on 2025-04-01
300
Participants Needed
2
Research Sites
21 weeks
Total Duration
R
Roland von Känel
Lead Sponsor
T
Triemli Hospital
Collaborating Sponsor
Researchers are working to develop a predictive model for clinically significant depressive symptoms (CSDS) in patients undergoing coronary artery bypass graft (CABG) surgery. CSDS affect about 30% of these patients, which is much higher than in the general population, and are linked to poorer quality of life and higher risks of illness and death. This project aims to use pre- and perioperative data to identify patients at risk for depression after surgery, helping clinicians make better prevention and management decisions. The study involves recruiting 350 patients from two hospitals undergoing elective off-pump CABG or CABG with or without valve intervention. Participants will be divided into a training group of 200 and a test group of 100 to develop and validate the prediction model. Data will include demographic, psychometric, medical, inflammation, and cardiac interoception information, analyzed using machine learning. The model will predict depression symptoms 6 weeks after surgery. Participants will be assessed before surgery and again 6 weeks post-surgery using questionnaires including the Patient Health Questionnaire (PHQ-9), General Anxiety Disorder (GAD-7) scale, PTSD Checklist (PCL-5), and Short-Form Health Survey (SF-12). The study will monitor mental and physical health changes and identify factors linked to postoperative depression. Participation involves following the study protocol and completing questionnaires at specified times, lasting through the 6-week post-surgery period.
CONDITIONS
Depressive Symptoms After Cardiac Surgery
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo baseline assessments including demographic, psychometric, medical, inflammation, and cardiac interoception data collection approximately 1 day before coronary artery bypass graft (CABG) surgery.
1 baseline visit (in-person)
Duration - Up to discharge
Participants undergo elective off-pump coronary artery bypass graft or coronary artery bypass graft surgery, alone or combined with valve intervention.
Surgery and hospital stay (in-person)
Duration - 6 weeks
Participants are monitored for clinically significant depressive symptoms and other psychological outcomes 6 weeks after CABG surgery to develop predictive models based on pre- and perioperative data.
1 follow-up visit (in-person) at 6 weeks post-surgery
Total: 2 locations
1
Stadtspital Zürich (City Hospital Zurich) Triemli
Zurich, Switzerland, 8063
Actively Recruiting
2
University Hospital Zurich (USZ)
Zurich, Switzerland, 8091
Not Yet Recruiting
R
Roland v Känel, Prof. Dr.
S
Sinthujan Sivakumar, MSc
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sidney Chocron, Pierre Vandel, Camille Durst...
https://pubmed.ncbi.nlm.nih.gov/23566649María Correa-Rodríguez, Moath Abu Ejheisheh, Nora Suleiman-Martos...
https://pubmed.ncbi.nlm.nih.gov/32225052Ping Guo
https://pubmed.ncbi.nlm.nih.gov/24894181Cleo Protogerou, Nigel Fleeman, Kerry Dwan...
https://pubmed.ncbi.nlm.nih.gov/26319588Simha Ravven, Caroline Bader, Armin Azar...
https://pubmed.ncbi.nlm.nih.gov/23656830Hisato Takagi, Tomo Ando, Takuya Umemoto...
https://pubmed.ncbi.nlm.nih.gov/28702898Phillip J Tully, Robert A Baker
https://pubmed.ncbi.nlm.nih.gov/22916068H U Wittchen, F Jacobi, J Rehm...
https://pubmed.ncbi.nlm.nih.gov/21896369